サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672051

喘息治療薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Asthma Therapeutics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 140 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
喘息治療薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 140 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の喘息治療薬の市場規模は、2024年の331億9,000万米ドルから2033年には513億6,000万米ドルに成長し、2026年～2033年の予測期間中に4.97％の堅調なCAGRを示すと予測されます。

喘息治療薬市場は、喘息の有病率の増加と効果的な治療オプションに対する需要の高まりによって、大幅な成長を遂げています。喘息管理に対する認識が向上するにつれ、医療提供者は、各患者固有のニーズに対応する個別化治療計画に注力しています。生物学的製剤や標的療法を含む喘息治療薬の革新は、喘息管理の状況を一変させ、重症でコントロール不能な喘息患者に新たな希望をもたらしています。これらの進歩は、服薬アドヒアランスとモニタリングを強化するスマート吸入器やデジタルヘルスソリューションの開発によって補完されています。

さらに、予防医療と早期介入を重視する傾向が強まっていることも、喘息治療薬市場に影響を与えています。医療システムが事前予防的な管理戦略を優先しているため、効果的な喘息治療薬の需要が急増しています。また、患者教育や自己管理への注目が高まることで、喘息をコントロールできるようになり、転帰の改善や医療費の削減につながります。

さらに、遠隔医療や遠隔モニタリング技術の台頭は、より良い喘息管理を促進しています。患者は、診察や経過観察のために医療専門家にアクセスすることができるようになり、来院する必要がなくなったため、病状管理が容易になりました。この動向は、遠隔診療が不可欠となっているCOVID-19パンデミックの状況において特に関連しています。結論として、喘息治療薬市場は、技術革新、個別化ケアの重視、喘息患者のQOL向上へのコミットメントを特徴とし、力強い成長が見込まれています。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供できるよう、綿密に作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクションです。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに分けています。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業を包括的に評価しています。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：実績データと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測しています。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 喘息治療薬の産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 喘息治療薬の世界市場分析：薬剤クラス別

  • 薬剤クラス別の概要
  • 薬剤クラス別の実績・予測データ分析
  • 併用療法（ICS/LABAs）
  • 長時間作用型β作動薬（LABAs）
  • 短時間作用型β作動薬（SABAs）
  • 吸入コルチコステロイド（ICS）
  • 経口および静脈内副腎皮質ステロイド薬
  • ロイコトリエン調節薬
  • その他

第6章 喘息治療薬の世界市場分析：治療タイプ別

  • 治療タイプ別の概要
  • 治療タイプ別の実績・予測データ分析
  • 長期喘息コントロール薬
  • 即効（レスキュー）薬

第7章 世界の喘息治療薬市場分析：投与経路別

  • 投与経路別の概要
  • 投与経路別の実績・予測データ分析
  • 局所
  • 経口
  • 注射

第8章 喘息治療薬の世界市場分析：流通チャネル別

  • 流通チャネル別の概要
  • 流通チャネル別の実績・予測データ分析
  • 実店舗
  • 院内薬局
  • eコマース

第9章 喘息治療薬の世界市場分析：最終用途別

  • 最終用途別の概要
  • 最終用途別の実績・予測データ分析
  • 病院・クリニック
  • 外来手術センター
  • 在宅医療

第10章 喘息治療薬の世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第11章 喘息治療薬企業の競合情勢

  • 喘息治療薬市場の競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品の上市
  • その他の開発

第12章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • AstraZeneca
  • Boehringer Ingelheim
  • Cipla Ltd.
  • Covis Pharma
  • GSK Plc
  • Merck & Co. Inc.
  • Novartis Pharmaceuticals Corporation
  • Regeneron Pharmaceuticals Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Drug Class (USD MN)
  • Combination Therapies (ICS/LABAs) Market Sales By Geography (USD MN)
  • Long-Acting Beta Agonists (LABAs) Market Sales By Geography (USD MN)
  • Short-Acting Beta Agonists (SABAs) Market Sales By Geography (USD MN)
  • Inhaled Corticosteroids (ICS) Market Sales By Geography (USD MN)
  • Oral And Intravenous Corticosteroids Market Sales By Geography (USD MN)
  • Leukotriene Modifiers Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Treatment Type (USD MN)
  • Long-Term Asthma Control Medications Market Sales By Geography (USD MN)
  • Quick-Relief (Rescue) Medications Market Sales By Geography (USD MN)
  • Analysis By Route Of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectables Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Brick & Mortar Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Global Asthma Therapeutics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Asthma Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Asthma Therapeutics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Drug Class
  • Market Attractiveness Analysis By Treatment Type
  • Market Attractiveness Analysis By Route Of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Drug Class (USD MN)
  • Combination Therapies (ICS/LABAs) Market Sales By Geography (USD MN)
  • Long-Acting Beta Agonists (LABAs) Market Sales By Geography (USD MN)
  • Short-Acting Beta Agonists (SABAs) Market Sales By Geography (USD MN)
  • Inhaled Corticosteroids (ICS) Market Sales By Geography (USD MN)
  • Oral And Intravenous Corticosteroids Market Sales By Geography (USD MN)
  • Leukotriene Modifiers Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment Type (USD MN)
  • Long-Term Asthma Control Medications Market Sales By Geography (USD MN)
  • Quick-Relief (Rescue) Medications Market Sales By Geography (USD MN)
  • Global Market Analysis By Route Of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectables Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Brick & Mortar Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11217451

Global Asthma Therapeutics Market size is anticipated to grow from USD 33.19 Billion in 2024 to USD 51.36 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.97% during the forecast period of 2026 to 2033.

The asthma therapeutics market is experiencing substantial growth, driven by the increasing prevalence of asthma and the rising demand for effective treatment options. As awareness of asthma management improves, healthcare providers are focusing on personalized treatment plans that address the unique needs of each patient. Innovations in asthma therapeutics, including biologics and targeted therapies, are transforming the landscape of asthma management, offering new hope for patients with severe and uncontrolled asthma. These advancements are complemented by the development of smart inhalers and digital health solutions that enhance medication adherence and monitoring.

Moreover, the growing emphasis on preventive care and early intervention is influencing the asthma therapeutics market. As healthcare systems prioritize proactive management strategies, the demand for effective asthma medications is surging. Additionally, the increasing focus on patient education and self-management is empowering individuals to take control of their asthma, leading to improved outcomes and reduced healthcare costs.

Furthermore, the rise of telemedicine and remote monitoring technologies is facilitating better asthma management. Patients can now access healthcare professionals for consultations and follow-ups without the need for in-person visits, making it easier to manage their condition. This trend is particularly relevant in the context of the COVID-19 pandemic, where remote care has become essential. In conclusion, the asthma therapeutics market is set for robust growth, characterized by innovation, a focus on personalized care, and a commitment to improving the quality of life for asthma patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Drug Class

  • Combination Therapies (ICS/LABAs)
  • Long-Acting Beta Agonists (LABAs)
  • Short-Acting Beta Agonists (SABAs)
  • Inhaled Corticosteroids (ICS)
  • Oral and Intravenous Corticosteroids
  • Leukotriene Modifiers
  • Other

By Treatment Type

  • Long-Term Asthma Control Medications
  • Quick-Relief (Rescue) Medications

By Route of Administration

  • Topical
  • Oral
  • Injectables

By Distribution Channel

  • Brick & Mortar
  • Hospital Pharmacies
  • E-Commerce

By End-Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings
  • COMPANIES PROFILED
  • AstraZeneca
  • Boehringer Ingelheim
  • Cipla Ltd.
  • Covis Pharma
  • GSK plc
  • Merck & Co. Inc.
  • Novartis Pharmaceuticals Corporation
  • Regeneron Pharmaceuticals Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ASTHMA THERAPEUTICS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Drug Class
    • 3.7.2 Market Attractiveness Analysis By Treatment Type
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By End-Use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

  • 5.1. Overview By Drug Class
  • 5.2. Historical and Forecast Data Analysis By Drug Class
  • 5.3. Combination Therapies (ICS/LABAs) Historic and Forecast Sales By Regions
  • 5.4. Long-Acting Beta Agonists (LABAs) Historic and Forecast Sales By Regions
  • 5.5. Short-Acting Beta Agonists (SABAs) Historic and Forecast Sales By Regions
  • 5.6. Inhaled Corticosteroids (ICS) Historic and Forecast Sales By Regions
  • 5.7. Oral And Intravenous Corticosteroids Historic and Forecast Sales By Regions
  • 5.8. Leukotriene Modifiers Historic and Forecast Sales By Regions
  • 5.9. Other Historic and Forecast Sales By Regions

6. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE

  • 6.1. Overview By Treatment Type
  • 6.2. Historical and Forecast Data Analysis By Treatment Type
  • 6.3. Long-Term Asthma Control Medications Historic and Forecast Sales By Regions
  • 6.4. Quick-Relief (Rescue) Medications Historic and Forecast Sales By Regions

7. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1. Overview By Route Of Administration
  • 7.2. Historical and Forecast Data Analysis By Route Of Administration
  • 7.3. Topical Historic and Forecast Sales By Regions
  • 7.4. Oral Historic and Forecast Sales By Regions
  • 7.5. Injectables Historic and Forecast Sales By Regions

8. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Brick & Mortar Historic and Forecast Sales By Regions
  • 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.5. E-Commerce Historic and Forecast Sales By Regions

9. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-Use
  • 9.2. Historical and Forecast Data Analysis By End-Use
  • 9.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 9.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 9.5. Homecare Settings Historic and Forecast Sales By Regions

10. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE ASTHMA THERAPEUTICS COMPANIES

  • 11.1. Asthma Therapeutics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF ASTHMA THERAPEUTICS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. AstraZeneca
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Boehringer Ingelheim
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Cipla Ltd.
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Covis Pharma
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. GSK Plc
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Merck & Co. Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Novartis Pharmaceuticals Corporation
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Regeneron Pharmaceuticals Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Sanofi
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Teva Pharmaceutical Industries Ltd
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies